
GeneSight Study Links Faster Relief to Test-Guided Care
Myriad Genetics, a leader in molecular diagnostic testing and precision medicine, announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study

Myriad Genetics, a leader in molecular diagnostic testing and precision medicine, announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study

Corvus, a digital health company dedicated to improving how surgical referrals are managed. Corvus helps care teams accelerate surgical access by automating referral workflows, ensuring

Christina Wang, MD, and Lynda Polgreen, MD, MS, investigators at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, have been awarded $9 million from the California

New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease. Counterpart Health, Inc., a wholly owned subsidiary

Randomized controlled trial results published in the International Journal of Tissue Repair demonstrate BioRetain allografts significantly improve probability of achieving lasting wound closure versus standard

As the Marketplace open enrollment begins, Ambetter Health, the health insurance product offered by Centene Corporation subsidiaries, a leading healthcare enterprise committed to helping people live healthier

Leading Data and Solutions Company Broadens Platform and Feature Sets Across Providers, Payers, Pharmacies, and Life Sciences to Advance Healthcare Inovalon, a leading provider of

The Region of Southern Denmark has signed a contract with Trifork for the development, implementation, and maintenance of the national Shared Public Treatment Platform. The

Vizient commends the U.S. Food and Drug Administration (FDA) for announcing actions to accelerate biosimilar development, including releasing new draft guidance that provides greater clarity on when comparative

The first patient has been dosed in the DESTINY-Lung06 phase 3 trial evaluating ENHERTU (trastuzumab deruxtecan) plus pembrolizumab versus pembrolizumab, platinum-based chemotherapy and pemetrexed as a first-line

Saama, a top provider of AI-based solutions in the Life Sciences industry, has launched its Tables, Listings, and Figures (TLF) Analyzer. This tool works with

Collectly, a leading provider of AI-driven patient billing and revenue cycle management solutions, has introduced Billie AI Eligibility & Benefits, a new platform designed to